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Abstract
Background: The long-term success of coronary artery bypass graft surgery (CABG) is
dependent on graft patency after the operation. Early occlusion (within the first week) affects
the long-term results. Therefore, we sought to determine pre-operative, intraoperative, and
perioperative factors associated with early coronary graft patency.
Methods: Between March 2007 and March 2008, 107 consecutive patients (81 men, 26 wo-
men, mean age 60 ± 9 years) who underwent CABG were included in this study. The enrolled
patients underwent 16-slice computed tomography angiography one week after CABG.
Results: Based on the multislice computed tomography, acute graft occlusion was detected in
32 (8.7% of all) grafts, including 26 of 250 (10%) in venous grafts and 6 of 116 (5%) in
arterial grafts. In univariate analysis, patients with patent coronary grafts had a lower serum
glucose level (119 ± 30 vs. 141 ± 65 mg/dL, p = 0.02) and longer partial thromboplastin time
(34 ± 11 vs. 30 ± 2 s, p = = 0.04). In addition, pump time was significantly longer in
patients with occluded grafts than in those with patent grafts (119 ± 43 vs. 102 ± 32 min, p = 0.04).
Those with longer pump time required more coronary grafts (pump time ≥ 120 min for
3.5 grafts vs. pump time < 120 min for 2.9 grafts, p = 0.02). Of the multiple pre-operative,
intraoperative, and perioperative characteristics of the patients who underwent successful
CABG, serum glucose level (OR: 2.014, 95% CI: 1.002–3.026, p = 0.002) and pump time
< two hours (OR: 1.502, 95% CI: 1.001–2.030, p = 0.003) were the only predictors of
coronary graft patency seven days after surgery in multivariate analysis.
Conclusions: Our study demonstrated that the patients with successful CABG and patent
coronary grafts within the first week after surgery had optimal blood glucose control and pump
time < two hours. (Cardiol J 2010; 17, 4: 344–348)
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Introduction
Coronary artery bypass graft (CABG) surgery
is the standard of care in the treatment of advanced
coronary artery disease. CABG provides excellent
short- and intermediate-term results in the manage-
ment of stable coronary artery disease; its long-term
results are affected by failure of venous graft [1].
Early occlusion (before hospital discharge) affects the
long-term results. Early occlusion has been found to
occur in 7 to 10% of coronary grafts [1]. Previous
studies have mainly evaluated the predictors of late
graft patency [2, 3].
The aim of this study was to evaluate pre-op-
erative, intraoperative, and perioperative factors
associated with early graft patency in patients who
underwent successful CABG.
Methods
Between March 2007 and March 2008, 107 con-
secutive patients (81 men, 26 women, mean age
60 ± 9 years) who underwent CABG were includ-
ed in this study. The enrolled patients underwent
16-slice computed tomography (CT) angiography
one week after CABG.
The study protocol was approved by the insti-
tution’s ethics committee and written informed
consent was obtained from all patients.
Exclusion criteria were: serum creatinine
>1.5 mg/dL, allergy to contrast material, hyperthy-
roidism, and inability to give informed consent.
A total of 366 grafts (250 venous grafts and 116 ar-
terial grafts) were evaluated, all of which could be
assessed for patency and occlusion using 16-slice
CT. Six patients (5.6%) had two grafts, 54 (50.5%)
had three grafts, 43 (40.2%) had four grafts, and four
(3.7%) had five grafts. Based on the multislice
copmputed tomography (MSCT), acute graft occlu-
sion was detected in 32 (8.7% of all) grafts, includ-
ing 26 of 250 (10%) in venous grafts and six of
116 (5%) in arterial grafts. All patients received as-
pirin, 325 mg daily, immediately after CABG.
Multidetector computed
tomography angiography protocol
Patients were scanned using a 16-section multi-
detector CT scanner (SOMATOM Sensation 16,
Siemens, Forchheim, Germany). Patients were po-
sitioned in the gantry supine and feet first, with
electrocardiographic leads placed on the anterior
thorax to enable a retrospectively gated scan. Scan
parameters were 140 kV, 0.4-second rotation speed,
400 mA, and 10 × 0.75 detectors. Pitch, which was
dependent on the heart rate, averaged 0.3. The CT
system automatically recommended a pitch value
to optimize the temporal resolution by the number
of sectors reconstructed from each scan. Scans
were performed in the caudal to cephalic direction,
with a scan range from the thoracic inlet through
the lung bases. The proximal subclavian arteries
were also included. To familiarize the patient with
the protocol, the exam, including breath-holding,
was practiced in advance. Beta-blockers (pro-
pranolol or esmolol) were injected intravenously for
heart rates exceeding 70 beats per minute, unless
underlying contraindications such as asthma were
present. A nonionic, iodinated, low-osmolar contrast
medium was injected intravenously in doses rang-
ing from 120 to 150 mL, without direct variation
with respect to patient weight. In addition, 20 mL
saline flush (saline chaser) was used to optimize the
graft visualization.
Data analysis
Variables are expressed as mean ± standard
deviation for the continuous variables and as abso-
lute or relative frequencies for categorical variables.
Chi-square test was used for categorical data and
Fisher exact test for cell count less than five. Pa-
tient characteristics were compared by means of
Student’s t-test in case of continuous variables.
Otherwise, a non-parametric test of Mann-Whitney
U test was used. A stepwise logistic regression
analysis was used to determine the independent
predictive factors for early graft patency. The va-
riables exhibiting differences between groups with
a p value < 0.10 in the univariate analysis were in-
cluded in the multivariate analysis. A two-tailed
p < 0.05 was considered statistically significant.
The software SPSS version 15.0 (SPSS Inc., Chicago,
IL, USA) was used for statistical analysis.
Results
The study population consisted of 107 conse-
cutive patients with CABG who completed the
MSCT protocol. Among the arterial grafts, 107
(96.4%) of 111 grafts to the left anterior descend-
ing artery (LAD) were classified as patent, where-
as one (33%) of the three grafts in the left circum-
flex (LCX) region and one (50%) of the two grafts
in the right coronary artery (RCA) territory were
found to be occluded. In the venous category, eight
(13.8%) of the 58 grafts to LAD were found to be
occluded. In the LCX region, nine (8.5%) of the
106 grafts were classified as occluded, while the re-
maining 97 (91.5%) grafts were patent. The venous
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The baseline clinical and demographic charac-
teristics were similar between the patients with
patent and occluded coronary grafts (Table 1). In
addition, early patency of coronary grafts was com-
parable irrespective of anti-ischemic therapy, pre-
operative left ventricular function, and coronary
artery anatomy (number of native vessels involved).
Two groups also showed no significant differen-
ces in the biochemical and hematological profiles
(Table 2). The only differences observed were
related to the baseline fasting blood sugar (FBS) and
partial thromboplastin time (PTT). The patients
with patent coronary grafts had lower serum FBS
level (119 ± 30 vs. 141 ± 65 mg/dL, p = 0.02) and
longer PTT (34 ± 11 vs. 30 ± 2 s, p = 0.04).
Intraoperative and perioperative
predictors of early graft patency
There were no differences in patency rate of
coronary grafts in terms of surgical technique (on-
pump vs. off-pump), saphenous vein graft (SVG)
location (bypass to LAD, RCA, or LCX), urgency of
surgery, need for packed cell transfusion, post-
Table 1. Comparison of baseline demographic and clinical characteristics in patients with patent and
occluded coronary grafts.
Variable Graft patent Graft occluded P
(n = 80) (n = 27)
Age (years) 59±9.6 60±8.3 0.63
Male 61 (76) 20 (74) 0.80
Number of native vessels involved 2.8 ± 0.37 2.9 ± 0.19 0.20
Total graft number 3.4 ± 0.65 3.4 ± 0.69 0.83
Diabetes 25 (31) 11 (41) 0.37
Insulin treatment in diabetes patients 8/25 (32) 0/11 (0) 0.03
Dyslipidemia 30 (37.5) 12 (44.4) 0.52
Smoking 25 (31) 5 (18.5) 0.20
Hypertension 33 (41) 10 (37) 0.70
Pre-operative LVEF 44 ± 8.5 46 ± 6.3 0.17
Nitrate 77 (96) 27 (100) 0.57
Calcium blocker 3 (3.8) 0 (0) 0.57
Beta-blocker 80 (100) 27 (100) 1.0
Values are n (%) or mean ± standard deviation; LVEF — left ventricular ejection fraction
Table 2. Comparison of baseline laboratory data in patients with patent and occluded coronary grafts.
Variable Graft patent Graft occluded P
(n = 80) (n = 27)
Fasting blood sugar [mg/dL] 119±30 141±65 0.02
Serum blood urea nitrogen [mg/dL] 20.7±6.3 20.7±4.8 0.99
Serum triglyceride [mg/dL] 165±80 169±81 0.79
Serum cholesterol [mg/dL] 184±53 178±43 0.60
Serum LDL-C [mg/dL] 110±44 116±40 0.52
Serum HDL-C [mg/dL] 33±8 33±7 0.95
Hemoglobin [g/dL] 11.4±1.6 11.6±1.5 0.07
White blood cell count (×103/µL) 9.125±3.804 8.529±4.020 0.82
Platelet count (×103/µL) 182.112±38.452 179.444±28.479 0.74
Partial thromboplastin time [s] 34±11 30±2 0.04
Prothrombin time [s] 12.8±1.5 12.7±1.0 0.64
LDL-C — low-density lipoprotein cholesterol; HDL-C — high-density lipoprotein cholesterol
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-operative bleeding, and post-operative cardiac arrest
(Table 3). However, pump time was significantly long-
er in patients with occluded grafts than those with
patent grafts (119 ± 43 vs. 102 ± 32 min, p = 0.04).
The patients with longer pump time required more
coronary grafts (pump time ≥ 120 min for 3.5 grafts
vs. pump time < 120 min for 2.9 grafts, p = 0.02).
Multivariate analysis
Of the multiple pre-operative, intraoperative,
and perioperative characteristics of the patients
who underwent successful CABG, serum FBS le-
vel (OR: 2.014, 95% CI: 1.002–3.026, p = 0.002) and
pump time two hours (OR: 1.502, 95% CI: 1.001–
–2.030, p = 0.003) were the only predictors of early
graft patency after CABG.
Discussion
This study shows that pre-operative serum
FBS and pump time are the two independent pre-
dictors of early coronary graft patency after CABG.
This study also confirmed an early patency rate of
more than 90% after CABG [4].
Diabetes has been reported to have an adverse
effect on surgical outcomes [5–9]. Interestingly, the
presence of diabetes mellitus itself did not predict
early graft patency in our study. However, pre-op-
erative serum FBS level was an important predic-
tor of early graft patency. Similarly, Godman et al.
[2] failed to find a relation between diabetes and
graft patency. This issue is also addressed in an-
other study on 517 patients with multi-vessel dis-
ease who underwent total arterial off-pump CABG
[10]. In the latter study, early post-operative and
one-year angiographies demonstrated similar paten-
cy rates in the diabetic and non-diabetic patients. The
association of  hyperglycemia with early graft oc-
clusion may be related to a hypercoagulable state
in poorly controlled patients with diabetes mellitus.
Boden et al. [11] demonstrated that acute normali-
zation of hyperglycemia with insulin resulted in sig-
nificant reduction of the tissue factor procoagulant
activity. Therefore, optimal FBS control, prefera-
bly with insulin, may significantly reduce the inci-
dence of coronary graft occlusion within the first
week of CABG.
Early occlusions of coronary bypass grafts usu-
ally occur in the first hours and days after surgery
and are thrombotic in origin. Therefore, it is expect-
ed to see a beneficial effect by antiplatelet and an-
ticoagulant agents on early graft patency. The bene-
ficial effect of aspirin on SVG patency has been
demonstrated in several studies [12–14]. In the
present study, aspirin was administered to all pa-
tients, precluding any comparison between treat-
ed and untreated patients. Data on the use of oral
anticoagulants in the prevention of SVG occlusion
is less clear than the data regarding aspirin [15–
–17]. In our study, prolonged PTT was protective
against the acute graft occlusion in univariate anal-
ysis. However, this difference disappeared in mul-
tivariate analysis, again demonstrating the contro-
versial effect of anticoagulant agents on early graft
patency.
The serum cholesterol and triglyceride levels
were not predictors of early graft patency in our
study population. Considering the pathophysiolo-
gical mechanism of early graft occlusion, we would
not expect to see a positive effect from an aggres-
sive lipid lowering strategy in reducing the inci-
dence of early graft occlusion. However, an aggres-
sive lipid lowering therapy has been associated with
improved late graft patency [2].
Table 3. Comparison of intraoperative and perioperative characteristics of patients with patent and
occluded grafts.
Variable Graft patent Graft occluded P
(n = 80) (n = 27)
On-pump vs. off-pump CABG 76 (95)/4 (5) 24 (89)/3 (11) 0.27
Graft location
SVG to LAD 45 (56) 13 (48) 0.51
SVG to LCX 80 (100) 26 (96) 0.86
SVG to RCA 62 (77.5) 24 (88.9) 0.20
Pump time [min] 102 ± 32 119 ± 43 0.04
Post-operative LVEF 43 ± 8 41 ± 9 0.27
Packed cell transfusion 56 (70) 19 (69.4) 0.98
Postoperative cardiac arrest 2 (2.5) 1 (3.7) 0.74
Values are n (%) or mean ± standard deviation; LVEF — left ventricular ejection fraction; CABG — coronary artery bypass graft; SVG — saphenous
vein graft; LAD — left anterior descending artery; LCX — left circumflex artery; RCA — right coronary artery
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Our data also demonstrated that operative fac-
tors, such as pump time, affect early graft patency.
This may be explained by the severity of coronary
artery disease, number of  grafted vessels, and  graft
location. The number of the involved vessels and
the SVG location were similar in patients with pa-
tent grafts and those with occluded grafts. The small
number of  arterial grafts in the LCX and the RCA
territories does not permit such a comparison. De-
spite the similar mean graft number, patients with
pump time ≥ two hours required more coronary
grafts than those who had shorter pump time.
A similar association has been demonstrated be-
tween pump time and late graft patency [3]. How-
ever, other operative factors, such as on-pump vs
off-pump surgery, elective vs. emergent surgery,
the need for packed cell transfusion, post-operative
bleeding, and post-operative cardiac arrest had no
effect on early graft patency.
Conclusions
The present study demonstrated that patients
with successful CABG and patent coronary grafts
within the first week after surgery are those who
had optimal FBS level and a pump time of less than
two hours.
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